Amerikanische Gesellschaft für Hirudotherapie

Albertus Magnus (Albert of Cologne)

c. 1200-1280 · Deutscher (Heiliges Römisches Reich) · Forschung

Biografische ReferenzHistorischer Eintrag
MittelalterForschung

Deutscher Dominikanermönch, Naturphilosoph und Bischof, dessen enzyklopädisches Werk De Animalibus aristotelische und islamische zoologische Wissensbestände, einschließlich der Naturgeschichte und medizinischen Verwendung von Blutegeln, in die lateinische scholastische Tradition integrierte.

Profil

Lebensjahre
c. 1200-1280
Nationalität
German (Holy Roman Empire)
Epoche
Mittelalter
Hauptfachgebiet
Forschung

Institutionelle Zugehörigkeiten

  • Order of Preachers (Dominicans)
  • University of Paris (Master of Theology, mid-thirteenth century)
  • Studium Generale of Cologne (founded by Albertus, 1248)
  • Diocese of Regensburg (Bishop, 1260-1262)

Wichtige Beiträge

  • Authored De Animalibus, a twenty-six-book zoological encyclopedia structured as a commentary on and expansion of Aristotle's biological works, transmitted with extensive supplementary observations.
  • Synthesized Aristotelian, Galenic, and Arabic medical and zoological learning into a single Latin reference accessible to thirteenth-century European scholars.
  • Documented contemporary observations on leeches as part of his broader natural history of aquatic animals, contributing to the medieval European understanding of leech biology and medical use.
  • Taught Thomas Aquinas at Cologne, helping to establish the Dominican intellectual tradition that integrated classical natural philosophy with theological learning.
  • Was canonized in 1931 and declared a Doctor of the Church and the patron saint of natural scientists, reflecting his role in legitimizing the scholarly study of nature within medieval Christendom.

Bedeutung für die Hirudotherapie

Albertus Magnus occupies an important transitional position in the medieval transmission of leech-related natural history and medicine into Latin Europe. By the mid-thirteenth century, the Aristotelian biological corpus and the medical writings of Galen and Avicenna had become available in Latin translation, and the universities of Paris, Bologna, and Padua were absorbing this accumulated learning. Albertus, working at Paris and later at Cologne, undertook the systematic project of commenting on the Aristotelian corpus and supplementing it with his own observations and with material drawn from Arabic, Greek, and Latin sources. Within De Animalibus, Albertus discusses aquatic invertebrates including leeches in the context of medieval zoology and natural philosophy. His treatment integrates classical and Islamic sources with his own observations on the appearance, habitat, and behavior of leeches available in Central European waterways. The text does not constitute a clinical manual of leech therapy in the manner of Avicenna's Canon, but it contributed to the broader scholarly framework within which medieval European physicians understood the medicinal leech as a recognized component of the materia medica. The American Society of Hirudotherapy regards Albertus Magnus as a representative figure of the medieval European scholastic tradition that preserved, transmitted, and elaborated the classical and Islamic learning on medicinal leeches across the centuries between antiquity and the Renaissance. His work illustrates the broader institutional context — universities, religious orders, episcopal libraries — through which leech-therapy doctrine retained continuous textual authority across the European medieval period until the rise of early-modern empirical medicine.

Wichtige Publikationen

  1. De Animalibus (On Animals) · Latin zoological encyclopedia (commentary on Aristotle) (1260)

Externe Ressourcen

Beeinflusste Forschung

Verbindungen und Forschungsbereiche, die auf die Beiträge dieser Persönlichkeit zurückgehen:

Verwandte Persönlichkeiten

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Freigabe für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.